Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • hssalgh2
    Junior Member
    • Jun 2017
    • 6

    #16
    Originally posted by Carcharodon View Post
    I see! Well, I'd recommend using a ratio slightly less than 1.8x. I'd lower that to 1.5x or so and see if it makes a difference (30 uL AmpureXP to 20 uL ladder dilution).
    Thanks. I have chosen this ratio because I am planning to do 16s rRNA amplicon sequencing so I have 96 samples and I will do nested PCR. So what do you think about this ?
    Many thanks

    Comment

    • Carcharodon
      Member
      • Jul 2015
      • 40

      #17
      Originally posted by hssalgh2 View Post
      Thanks. I have chosen this ratio because I am planning to do 16s rRNA amplicon sequencing so I have 96 samples and I will do nested PCR. So what do you think about this ?
      Many thanks
      I don't think it should be much of a problem, unless I'm misunderstanding something. If the lower ratio is a concern, I would recommend taking one (or a few) of your PCR products and trying both ratios on them, running them out on a gel.

      So on the gel you would run:

      1) PCR Product w/o cleanup
      2) PCR Product w/ cleanup at 1.8x
      3) PCR Product w/ cleanup at 1.5x

      ...and see if there's a difference.

      It's a bit of extra work, but it's a small price to pay for peace of mind. This approach may also be better than testing on a ladder, since you'll be working with the PCR products directly (rather than with a ladder which may or may not have an inhibitory effect on the SPRI beads).

      Comment

      • hssalgh2
        Junior Member
        • Jun 2017
        • 6

        #18
        Originally posted by Carcharodon View Post
        I don't think it should be much of a problem, unless I'm misunderstanding something. If the lower ratio is a concern, I would recommend taking one (or a few) of your PCR products and trying both ratios on them, running them out on a gel.

        So on the gel you would run:

        1) PCR Product w/o cleanup
        2) PCR Product w/ cleanup at 1.8x
        3) PCR Product w/ cleanup at 1.5x

        ...and see if there's a difference.

        It's a bit of extra work, but it's a small price to pay for peace of mind. This approach may also be better than testing on a ladder, since you'll be working with the PCR products directly (rather than with a ladder which may or may not have an inhibitory effect on the SPRI beads).
        Ok. I will do waht you suggested. Then I see
        I am thinking about PCR cycling for the first round is 18 cycle and in the second round is25cycle so is it ok to increase the cycle in the first round to 35 cycle what do you suggest?
        Many thanks

        Comment

        • Carcharodon
          Member
          • Jul 2015
          • 40

          #19
          Originally posted by hssalgh2 View Post
          Ok. I will do waht you suggested. Then I see
          I am thinking about PCR cycling for the first round is 18 cycle and in the second round is25cycle so is it ok to increase the cycle in the first round to 35 cycle what do you suggest?
          Many thanks
          This is probably better left for someone else to answer. I don't have any real experience with this protocol. I've gone toe-to-toe with the beads more than a few times, but nested PCR is another story.

          Comment

          • nucacidhunter
            Jafar Jabbari
            • Jan 2013
            • 1250

            #20
            Originally posted by hssalgh2 View Post
            Ok. I will do waht you suggested. Then I see
            I am thinking about PCR cycling for the first round is 18 cycle and in the second round is25cycle so is it ok to increase the cycle in the first round to 35 cycle what do you suggest?
            Many thanks
            It depends on your experiment and input. It is not clear if you are preparing 16S region specific library for sequencing on Illumina systems or whole 16S for long read sequencing.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 12:17 PM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 11:41 AM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...